Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy
Zu Ye, Shi Yin, Susan P. Lees‐Miller, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

GRB2 stabilizes RAD51 at reversed replication forks suppressing genomic instability and innate immunity against cancer
Zu Ye, Shengfeng Xu, Yin Shi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Review: Protein O-GlcNAcylation regulates DNA damage response: A novel target for cancer therapy
Zhuang Zhu, Shaoming Li, Xiaopeng Yin, et al.
International Journal of Biological Macromolecules (2024) Vol. 264, pp. 130351-130351
Closed Access | Times Cited: 6
The future of cancer treatment: combining radiotherapy with immunotherapy
Gunjan Dagar, Ashna Gupta, Abhishek Shankar, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access | Times Cited: 6
Rise of the natural red pigment ‘prodigiosin’ as an immunomodulator in cancer
Mohammed Moustapha Anwar, Chris Albanese, Nadia Μ. Hamdy, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 26
DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival
Chara Papalouka, Maria Adamaki, Panagiota Batsaki, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2760-2760
Open Access | Times Cited: 15
DNA Repair Deficiency Regulates Immunity Response in Cancers: Molecular Mechanism and Approaches for Combining Immunotherapy
Yi Xu, Somaira Nowsheen, Min Deng
Cancers (2023) Vol. 15, Iss. 5, pp. 1619-1619
Open Access | Times Cited: 15
When DNA damage responses meet tumor immunity: From mechanism to therapeutic opportunity
Dong Pan, Qi Wang, AiHua Shen, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 3, pp. 384-399
Closed Access | Times Cited: 5
Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer
Shiwei Yue, Yunpu Zhang, Wei Zhang
Current Treatment Options in Oncology (2024) Vol. 25, Iss. 8, pp. 1089-1111
Open Access | Times Cited: 5
Anti-cancer immune responses to DNA damage response inhibitors: Molecular mechanisms and progress toward clinical translation
Lindsey Carlsen, Wafik S. El‐Deiry
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 21
For Better or Worse: Modulation of the Host DNA Damage Response by Human Papillomavirus
Caleb J. Studstill, Cary A. Moody
Annual Review of Virology (2023) Vol. 10, Iss. 1, pp. 325-345
Open Access | Times Cited: 12
FANCD2 and RAD51 recombinase directly inhibit DNA2 nuclease at stalled replication forks and FANCD2 acts as a novel RAD51 mediator in strand exchange to promote genome stability
Wenpeng Liu, Piotr Polaczek, Ivan Roubal, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. 17, pp. 9144-9165
Open Access | Times Cited: 12
Crosstalk between Wnt/β-catenin signaling pathway and DNA damage response in cancer: a new direction for overcoming therapy resistance
Xixia Zhang, Xiaofeng Yu
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
For better or worse: crosstalk of parvovirus and host DNA damage response
Songbiao Chen, Feifei Liu, Aofei Yang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects
Hyosang Kwak, Ein Lee, Rajendra Karki
Immunological Reviews (2024)
Open Access | Times Cited: 4
Insight into the anti-cancer and anti-viral therapeutic properties of biological active molecule prodigiosin
Atif Shafqat
Asia-Pacific Journal of Pharmacotherapy & Toxicology (2025)
Closed Access
Los olvidados: Non-BRCA variants associated with Hereditary breast cancer in Mexican population
Dione Aguilar, María Lourdes Garza-Rodríguez, Carolina Elizabeth Muñiz-Garza, et al.
Breast Cancer Research (2025) Vol. 27, Iss. 1
Open Access
Non-enzymatic protein targeting agents as a promising strategy for cancer treatment
M. Ambrose, Jin-Hyung Lee, Aleem Syed, et al.
Frontiers in Drug Discovery (2025) Vol. 5
Open Access
PRR11 Promotes Bladder Cancer Growth and Metastasis by Facilitating G1/S Progression and Epithelial‐Mesenchymal Transition
Lu Wang, Zengshun Kou, Jiaxi Zhu, et al.
Cancer Medicine (2025) Vol. 14, Iss. 5
Open Access
Multi-omics analysis identifies DLX4 as a novel biomarker for diagnosis, prognosis, and immune infiltration: from pan-cancer to renal cancer
Zengshun Kou, Shuaizhi Zhu, Jiaxi Zhu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair
Jeremy M. Kelm, Amirreza Samarbakhsh, Athira Pillai, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18
The immunotoxicity of natural and depleted uranium: From cells to people
Jodi R. Schilz, Erica J. Dashner-Titus, Karen A. Simmons, et al.
Toxicology and Applied Pharmacology (2022) Vol. 454, pp. 116252-116252
Open Access | Times Cited: 17
Immunogenic chemotherapy: great potential for improving response rates
Xiaojun Huang, Qinghuan Ren, Leixiang Yang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 10
Adjudicative efficacy of Bifidobacterium animalis subsp. lactis BLa80 in treating acute diarrhea in children: a randomized, double-blinded, placebo-controlled study
Ke Chen, Shanshan Jin, Yu Ma, et al.
European Journal of Clinical Nutrition (2024) Vol. 78, Iss. 6, pp. 501-508
Open Access | Times Cited: 3
Molecular Pathways and Mechanisms of TGFβ in Cancer Therapy
Mary Helen Barcellos‐Hoff, James L. Gulley
Clinical Cancer Research (2023) Vol. 29, Iss. 11, pp. 2025-2033
Open Access | Times Cited: 9
Adjunctive efficacy of Lactis XLTG11 for Acute diarrhea in children: A randomized, blinded, placebo-controlled study
Ke Chen, Shanshan Jin, Yu Ma, et al.
Nutrition (2023) Vol. 111, pp. 112052-112052
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top